Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Apr;91(4):1769–1774. doi: 10.1172/JCI116387

Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.

P Szulc 1, M C Chapuy 1, P J Meunier 1, P D Delmas 1
PMCID: PMC288157  PMID: 8473517

Abstract

It has been previously shown that the level of circulating undercarboxylated osteocalcin (ucOC) is elevated in elderly women in comparison with young, healthy, premenopausal ones. To understand the mechanism of the increase in the ucOC in the elderly and to assess its potential consequences on bone fragility, we have measured ucOC in the sera of 195 elderly institutionalized women 70-101 yr of age. In 45 women (23%) serum ucOC was above the upper limit of the normal range for young women. The level of ucOC was negatively correlated with 25OHD (r = -0.32, P < 0.001) even after excluding the effect of age, parathyroid hormone (PTH), and creatinine by partial correlation (r = -0.24, P < 0.002). During an 18-mo follow-up, 15 women sustained a hip fracture and their baseline ucOC level was higher (P < 0.01) in women who subsequently sustained hip fracture than in the nonfracture group contrasting with no significant differences for serum calcium, phosphate, alkaline phosphatase, creatinine, PTH, 250HD, and total and carboxylated OC. The risk of hip fracture was increased in women with elevated ucOC (relative ratio 5.9, 99.9% Cl 1.5-22.7, P < 0.001). During 1 yr of calcium/vitamin D2 treatment, ucOC decreased (P < 0.05), especially in those with the initially increased values (from 2.22 +/- 0.35 to 1.41 +/- 0.29 ng/ml, P <0.005) contrasting with an increase in the placebo group (P < 0.05). In conclusion, the increase in ucOC in the elderly reflects not only some degree of vitamin K deficiency but also their poor vitamin D status, suggesting that vitamin D may be important, either directly or indirectly through its effect on bone turnover, for achieving a normal gamma-carboxylation of OC. The ucOC, but not conventional calcium metabolism parameters, predicts the subsequent risk of hip fracture, suggesting that serum ucOC reflects some changes in bone matrix associated with increased fragility.

Full text

PDF
1769

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chapuy M. C., Arlot M. E., Duboeuf F., Brun J., Crouzet B., Arnaud S., Delmas P. D., Meunier P. J. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992 Dec 3;327(23):1637–1642. doi: 10.1056/NEJM199212033272305. [DOI] [PubMed] [Google Scholar]
  2. Chapuy M. C., Chapuy P., Meunier P. J. Calcium and vitamin D supplements: effects on calcium metabolism in elderly people. Am J Clin Nutr. 1987 Aug;46(2):324–328. doi: 10.1093/ajcn/46.2.324. [DOI] [PubMed] [Google Scholar]
  3. DeFranco D. J., Glowacki J., Cox K. A., Lian J. B. Normal bone particles are preferentially resorbed in the presence of osteocalcin-deficient bone particles in vivo. Calcif Tissue Int. 1991 Jul;49(1):43–50. doi: 10.1007/BF02555901. [DOI] [PubMed] [Google Scholar]
  4. Delmas P. D. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am. 1990 Mar;19(1):1–18. [PubMed] [Google Scholar]
  5. Demiaux B., Arlot M. E., Chapuy M. C., Meunier P. J., Delmas P. D. Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. J Clin Endocrinol Metab. 1992 May;74(5):1146–1151. doi: 10.1210/jcem.74.5.1569162. [DOI] [PubMed] [Google Scholar]
  6. Deyl Z., Adam M. Evidence for vitamin D dependent gamma-carboxylation in osteocalcin related proteins. Biochem Biophys Res Commun. 1983 May 31;113(1):294–300. doi: 10.1016/0006-291x(83)90465-5. [DOI] [PubMed] [Google Scholar]
  7. Eastwood J. B., de Wardener H. E., Gray R. W., Lemann J. L., Jr Normal plasma-1,25-(OH)2-vitamin-D concentrations in nutritional osteomalacia. Lancet. 1979 Jun 30;1(8131):1377–1378. doi: 10.1016/s0140-6736(79)92012-9. [DOI] [PubMed] [Google Scholar]
  8. Feteih R., Tassinari M. S., Lian J. B. Effect of sodium warfarin on vitamin K-dependent proteins and skeletal development in the rat fetus. J Bone Miner Res. 1990 Aug;5(8):885–894. doi: 10.1002/jbmr.5650050813. [DOI] [PubMed] [Google Scholar]
  9. Fiore C. E., Tamburino C., Foti R., Grimaldi D. Reduced axial bone mineral content in patients taking an oral anticoagulant. South Med J. 1990 May;83(5):538–542. doi: 10.1097/00007611-199005000-00013. [DOI] [PubMed] [Google Scholar]
  10. Furie B., Furie B. C. Molecular basis of vitamin K-dependent gamma-carboxylation. Blood. 1990 May 1;75(9):1753–1762. [PubMed] [Google Scholar]
  11. Gehron Robey P. The biochemistry of bone. Endocrinol Metab Clin North Am. 1989 Dec;18(4):858–902. [PubMed] [Google Scholar]
  12. Glowacki J., Lian J. B. Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants. Cell Differ. 1987 Sep;21(4):247–254. doi: 10.1016/0045-6039(87)90479-9. [DOI] [PubMed] [Google Scholar]
  13. Hart J. P., Shearer M. J., Klenerman L., Catterall A., Reeve J., Sambrook P. N., Dodds R. A., Bitensky L., Chayen J. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J Clin Endocrinol Metab. 1985 Jun;60(6):1268–1269. doi: 10.1210/jcem-60-6-1268. [DOI] [PubMed] [Google Scholar]
  14. Himmelstein S., Clemens T. L., Rubin A., Lindsay R. Vitamin D supplementation in elderly nursing home residents increases 25(OH)D but not 1,25(OH)2D. Am J Clin Nutr. 1990 Oct;52(4):701–706. doi: 10.1093/ajcn/52.4.701. [DOI] [PubMed] [Google Scholar]
  15. Hodges S. J., Pilkington M. J., Shearer M. J., Bitensky L., Chayen J. Age-related changes in the circulating levels of congeners of vitamin K2, menaquinone-7 and menaquinone-8. Clin Sci (Lond) 1990 Jan;78(1):63–66. doi: 10.1042/cs0780063. [DOI] [PubMed] [Google Scholar]
  16. Hodges S. J., Pilkington M. J., Stamp T. C., Catterall A., Shearer M. J., Bitensky L., Chayen J. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone. 1991;12(6):387–389. doi: 10.1016/8756-3282(91)90027-g. [DOI] [PubMed] [Google Scholar]
  17. Karl P. I., Friedman P. A. Effects of parathyroid hormone and vitamin D on the renal vitamin K-dependent carboxylating system. J Biol Chem. 1983 Nov 10;258(21):12783–12786. [PubMed] [Google Scholar]
  18. Kelsey J. L., Hoffman S. Risk factors for hip fracture. N Engl J Med. 1987 Feb 12;316(7):404–406. doi: 10.1056/NEJM198702123160709. [DOI] [PubMed] [Google Scholar]
  19. Knapen M. H., Hamulyák K., Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med. 1989 Dec 15;111(12):1001–1005. doi: 10.7326/0003-4819-111-12-1001. [DOI] [PubMed] [Google Scholar]
  20. Lian J. B., Glimcher M. J., Roufosse A. H., Hauschka P. V., Gallop P. M., Cohen-Solal L., Reit B. Alterations of the gamma-carboxyglutamic acid and osteocalcin concentrations in vitamin D-deficient chick bone. J Biol Chem. 1982 May 10;257(9):4999–5003. [PubMed] [Google Scholar]
  21. Lian J. B., Tassinari M., Glowacki J. Resorption of implanted bone prepared from normal and warfarin-treated rats. J Clin Invest. 1984 Apr;73(4):1223–1226. doi: 10.1172/JCI111308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lian J., Stewart C., Puchacz E., Mackowiak S., Shalhoub V., Collart D., Zambetti G., Stein G. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1143–1147. doi: 10.1073/pnas.86.4.1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lips P., Wiersinga A., van Ginkel F. C., Jongen M. J., Netelenbos J. C., Hackeng W. H., Delmas P. D., van der Vijgh W. J. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab. 1988 Oct;67(4):644–650. doi: 10.1210/jcem-67-4-644. [DOI] [PubMed] [Google Scholar]
  24. Menon R. K., Gill D. S., Thomas M., Kernoff P. B., Dandona P. Impaired carboxylation of osteocalcin in warfarin-treated patients. J Clin Endocrinol Metab. 1987 Jan;64(1):59–61. doi: 10.1210/jcem-64-1-59. [DOI] [PubMed] [Google Scholar]
  25. Merle B., Delmas P. D. Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone. Bone Miner. 1990 Nov;11(2):237–245. doi: 10.1016/0169-6009(90)90062-k. [DOI] [PubMed] [Google Scholar]
  26. Monreal M., Olive A., Lafoz E., del Rio L. Heparins, coumarin, and bone density. Lancet. 1991 Sep 14;338(8768):706–706. doi: 10.1016/0140-6736(91)91292-3. [DOI] [PubMed] [Google Scholar]
  27. Parfitt A. M. Chlorothiazide-induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. N Engl J Med. 1969 Jul 10;281(2):55–59. doi: 10.1056/NEJM196907102810201. [DOI] [PubMed] [Google Scholar]
  28. Parfitt A. M., Gallagher J. C., Heaney R. P., Johnston C. C., Neer R., Whedon G. D. Vitamin D and bone health in the elderly. Am J Clin Nutr. 1982 Nov;36(5 Suppl):1014–1031. doi: 10.1093/ajcn/36.5.1014. [DOI] [PubMed] [Google Scholar]
  29. Plantalech L., Guillaumont M., Vergnaud P., Leclercq M., Delmas P. D. Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women. J Bone Miner Res. 1991 Nov;6(11):1211–1216. doi: 10.1002/jbmr.5650061111. [DOI] [PubMed] [Google Scholar]
  30. Price P. A., Sloper S. A. Concurrent warfarin treatment further reduces bone mineral levels in 1,25-dihydroxyvitamin D3-treated rats. J Biol Chem. 1983 May 25;258(10):6004–6007. [PubMed] [Google Scholar]
  31. Price P. A., Williamson M. K. Effects of warfarin on bone. Studies on the vitamin K-dependent protein of rat bone. J Biol Chem. 1981 Dec 25;256(24):12754–12759. [PubMed] [Google Scholar]
  32. Price P. A., Williamson M. K., Haba T., Dell R. B., Jee W. S. Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7734–7738. doi: 10.1073/pnas.79.24.7734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Price P. A., Williamson M. K., Lothringer J. W. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem. 1981 Dec 25;256(24):12760–12766. [PubMed] [Google Scholar]
  34. Ray W. A., Griffin M. R., Schaffner W., Baugh D. K., Melton L. J., 3rd Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987 Feb 12;316(7):363–369. doi: 10.1056/NEJM198702123160702. [DOI] [PubMed] [Google Scholar]
  35. Resch H., Pietschmann P., Krexner E., Willvonseder R. Decreased peripheral bone mineral content in patients under anticoagulant therapy with phenprocoumon. Eur Heart J. 1991 Mar;12(3):439–441. doi: 10.1093/oxfordjournals.eurheartj.a059914. [DOI] [PubMed] [Google Scholar]
  36. Toss G., Almqvist S., Larsson L., Zetterqvist H. Vitamin D deficiency in welfare institutions for the aged. Acta Med Scand. 1980;208(1-2):87–89. doi: 10.1111/j.0954-6820.1980.tb01157.x. [DOI] [PubMed] [Google Scholar]
  37. Tsai K. S., Heath H., 3rd, Kumar R., Riggs B. L. Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis. J Clin Invest. 1984 Jun;73(6):1668–1672. doi: 10.1172/JCI111373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. van Haarlem L. J., Knapen M. H., Hamulyák K., Vermeer C. Circulating osteocalcin during oral anticoagulant therapy. Thromb Haemost. 1988 Aug 30;60(1):79–82. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES